Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses.

MLA

Maurer, Tobias, et al. “Immunostimulatory CpG-DNA and PSA-Peptide Vaccination Elicits Profound Cytotoxic T Cell Responses.” Urologic Oncology, vol. 31, no. 7, Oct. 2013, pp. 1395–401. EBSCOhost, https://doi.org/10.1016/j.urolonc.2011.09.002.

APA

Maurer, T., Pournaras, C., Aguilar-Pimentel, J. A., Thalgott, M., Horn, T., Heck, M., Heit, A., Kuebler, H., Gschwend, J. E., & Nawroth, R. (2013). Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses. Urologic Oncology, 31(7), 1395–1401. https://doi.org/10.1016/j.urolonc.2011.09.002

Chicago

Maurer, Tobias, Christos Pournaras, Juan A. Aguilar-Pimentel, Mark Thalgott, Thomas Horn, Matthias Heck, Antje Heit, Hubert Kuebler, Jürgen E. Gschwend, and Roman Nawroth. 2013. “Immunostimulatory CpG-DNA and PSA-Peptide Vaccination Elicits Profound Cytotoxic T Cell Responses.” Urologic Oncology 31 (7): 1395–1401. doi:10.1016/j.urolonc.2011.09.002.